Filing Details
- Accession Number:
- 0001104659-23-119646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-17 20:01:13
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-17 20:01:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1737953 | Replimune Group Inc. | REPL | Biological Products, (No Disgnostic Substances) (2836) | 822082553 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1956241 | Konstantinos Xynos | C/O Replimune Group, Inc. 500 Unicorn Park Drive Woburn MA 01801 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-16 | 7,313 | $10.92 | 112,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.
- The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.92 to $11.09. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
